Assessment of the Prevalence of De Novo Mutations in the BRCA1 and BRCA2 Genes
Overview
Affiliations
Felix G, Abe-Sandes C, Machado-Lopes T, Bomfim T, Guindalini R, Santos V Hum Genome Var. 2016; 1:14012.
PMID: 27081505 PMC: 4785545. DOI: 10.1038/hgv.2014.12.
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations.
Golmard L, Delnatte C, Lauge A, Moncoutier V, Lefol C, Abidallah K Oncogene. 2015; 35(10):1324-7.
PMID: 26028024 DOI: 10.1038/onc.2015.181.
Low-level constitutional mosaicism of a de novoBRCA1 gene mutation.
Friedman E, Efrat N, Soussan-Gutman L, Dvir A, Kaplan Y, Ekstein T Br J Cancer. 2015; 112(4):765-8.
PMID: 25633036 PMC: 4333503. DOI: 10.1038/bjc.2015.14.